Literature DB >> 12706681

Hepatitis B carriers in large vehicle drivers of Iran.

Mohammad Reza Jahani1, Seyed Abbas Motevalian, Mahmood Mahmoodi.   

Abstract

Hepatitis B is a serious cause of mortality and morbidity worldwide. The prevalence of hepatitis B surface antigen in Iran is about 1.7% but little is known about the high-risk occupations. This study was conducted to investigate the prevalence of HBsAg and assess risk factors of infection in Iran's large vehicle drivers as a high-risk group. The population studied included 1113 large vehicle drivers. Study was carried out in 51 police stations in roads of 17 provinces around the country. From each of the sites 20-30 large vehicle drivers were randomly selected. An interview with each of the subjects was performed and a blood sample was taken. The prevalence of HBsAg was 5.9% (confidence interval (CI) 95%: 4.5-7.3%) which was significantly different from the prevalence in general population in the same age group (P<0.0001). Cost-effectiveness studies regarding immunization programs for this high-risk group is suggested.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706681     DOI: 10.1016/s0264-410x(02)00805-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries.

Authors:  Bilal Ahmed; Tooba Ali; Huma Qureshi; Saeed Hamid
Journal:  Hepatol Int       Date:  2013-01-10       Impact factor: 6.047

2.  Prevalence of chronic hepatitis B infection in Iran: a review article.

Authors:  Jalal Poorolajal; Reza Majdzadeh
Journal:  J Res Med Sci       Date:  2009-07       Impact factor: 1.852

3.  Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran.

Authors:  Mohammad Reza Ghadir; Mojtaba Belbasi; Akram Heidari; Mahboobeh Jandagh; Iman Ahmadi; Hosseinali Habibinejad; Alireza Kabiri; Amir Hossein Ghanooni; Abolfazl Iranikhah; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

4.  The Seroprevalence of Hepatitis B in Akbar Abad Village, Kavar, Southern Iran.

Authors:  Mohammad Reza Fattahi; Davood Mehrabani; Sara Mehvarz; Najmeh Zarei Jaliani; Abbas Alipour; Mohammad Ali Davarpanah
Journal:  Int J Prev Med       Date:  2014-12

5.  Prevalence of Hepatitis B virus between Qeshm Island people in 2013-2014, Iran.

Authors:  A Kargar Kheirabad; E Elmira Jokari; M J Sajjadi; H Gouklani
Journal:  J Med Life       Date:  2015

6.  Hepatitis B knowledge among Iranian adolescents: a national survey.

Authors:  Nader Roushan; Mohsen Nasiri Toosi; Alipasha Meysamie; Abdoul-Reza Esteghamati; Homazad Hajrassuliha
Journal:  Iran Red Crescent Med J       Date:  2013-12-05       Impact factor: 0.611

7.  Diagnostic validity of the chemiluminescent method compared to polymerase chain reaction for hepatitis B virus detection in the routine clinical diagnostic laboratory.

Authors:  Mohammad-Hassan Khadem-Ansari; Mir-Davood Omrani; Yousef Rasmi; Arsalan Ghavam
Journal:  Adv Biomed Res       Date:  2014-05-28

Review 8.  Hepatocellular carcinoma in the world and the middle East.

Authors:  H Poustchi; Sg Sepanlou; S Esmaili; N Mehrabi; A Ansarymoghadam
Journal:  Middle East J Dig Dis       Date:  2010-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.